Literature DB >> 30890584

Vogt-Koyanagi-Harada disease.

Duncan Street1, Arul Sivaguru2, Sreekanth Sreekantam3, Susan P Mollan4,5.   

Abstract

Vogt-Koyanagi-Harada disease is a rare, multisystem, autoimmune disorder with numerous clinical manifestations, mediated through a T-helper 1 response against melanocytes in the eye, inner ear, central nervous system, hair and skin. We describe a 20-year-old British-Honduran man with recent worsening headache and photophobia, vomiting and visual blurring. On examination, his pupils reacted sluggishly and visual acuities were bilaterally reduced. Optical coherence tomography showed gross retinal swelling and neurosensory detachments. MR scan of the brain was normal, but cerebrospinal fluid showed a reactive picture with 258 ×109 lymphocytes./L (normal ≤5×109/L). Following treatment with immunosuppression (prednisolone, tacrolimus, mycophenolate mofetil, adalimumab), he made a full recovery. Clinicians should consider Vogt-Koyanagi-Harada disease in patients presenting with headache with acute profound visual loss. A prompt diagnosis and immunosuppressive therapy can lead to complete resolution. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  headache; neuroophthalmology; vision

Year:  2019        PMID: 30890584     DOI: 10.1136/practneurol-2018-002152

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  2 in total

1.  Case Report: Vogt-Koyanagi-Harada Syndrome Mimicking Acute Angle-Closure Glaucoma in a Patient Infected With Human Immunodeficiency Virus.

Authors:  Xue Bai; Rui Hua
Journal:  Front Med (Lausanne)       Date:  2022-01-12

2.  Adalimumab in Vogt-Koyanagi-Harada Disease Refractory to Conventional Therapy.

Authors:  Shizhao Yang; Tianyu Tao; Zhaohao Huang; Xiuxing Liu; He Li; Lihui Xie; Feng Wen; Wei Chi; Wenru Su
Journal:  Front Med (Lausanne)       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.